were suppressed, and glomerular hypertrophy, which may relate to haemodynamic burden such as hyperBackground. Prolonging the survival of transplant kidneys is a major task of modern nephrology. It has filtration, was prominent. Preliminary study of ACEinhibitor treatment in 10 patients showed favourable recently been shown that deteriorating renal function and substantial graft loss were observed in 55% of effects. A future long-term follow-up study is required to establish the effectiveness of ACE inhibitors in renal allograft recipients with recurrent IgA nephropathy (IgAN ) at long-term follow-up. To gain a useful treatment of post-transplant IgAN. insight into the therapeutic approach towards protecting allograft kidneys from deteriorating graft func-Keywords: ACE inhibitors; graft function loss; tion, we compared the histological characteristics of hyperfiltration; kidney allograft; post-transplant IgA post-transplant IgAN to primary IgAN and investi-nephropathy gated the effects of an ACE inhibitor. Methods. Twenty-one patients with post-transplant IgAN and 63 patients with primary IgAN were included in the histopathological study. The effect-Introduction iveness of angiotensin-converting enzyme (ACE) inhibitor treatment in post-transplant IgAN was also studied Renal transplantation is universally considered to be in 10 patients. the treatment of choice for patients with end-stage Results. The prevalence of glomeruli with adhesions renal disease, providing good patient survival and and/or cellular crescents in primary IgAN was significquality of life. Recent improvements in immunoantly greater than in post-transplant IgAN (P<0.05), suppressive therapy have led to a dramatic increase in but the proportion of glomeruli with segmental sclershort-term renal allograft survival. However, acceptosis was similar in both groups. The rate of global able improvements in long-term allograft survival have obsolescence, and the degree of interstitial fibrosis in not been achieved. After the first year, the number of post-transplant IgAN were significantly greater than functioning grafts begins to decline, to approximately in primary IgAN (P<0.05). The degree of glomerular 70%, and to less than 50% at 5 and 10 years after obsolescence and the severity of interstitial fibrosis transplantation, respectively. Prolonging the survival correlated with the severity of glomerular lesion in of transplanted kidneys is, therefore, a major task of primary IgAN, but not in post-transplant IgAN. In modern nephrology. primary IgAN, glomerular diameter significantly corCurrently, post-transplant IgA nephropathy (IgAN ) related with the proportions of glomerular obsolesis considered to include recurrence of IgAN, de novo cence, but not in post-transplant IgAN, suggesting that IgAN, or transmission of IgA deposit from donor allograft kidneys may be in a hyperfiltration state.
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kidney [1] . Yamaguchi et al. [2] reported that the Both the blood pressure and the urinary protein prevalence of post-transplant IgAN was 34% in renal excretion significantly improved after ACE-inhibitor biopsies of allografts surviving more than 5 years. treatment (P<0.001).
Berger et al. [3] were the first to describe recurrence Conclusion. In post-transplant IgAN, histopathologof IgA deposit, and subsequent studies showed 50-60% ical lesions indicative of acute inflammatory insults prevalence of recurrent IgAN. Graft loss due to recurrent renal diseases has been reported to be a rare event, Correspondence and offprint requests to: Enyu Imai MD, PhD, estimated as less than 5% [4]. However, it has recently Department of Internal Medicine and Therapeutics, Osaka been shown that deteriorating renal function and sub-appearance of abnormal urinalysis to renal biopsy in 17 allograft recipients with recurrent IgAN at long-term patients was more than 3 years. Three patients had experifollow-up [5] [6] [7] . enced acute rejection in the past, which had been diagnosed It appears that normal blood pressure is a good changes in the glomeruli, interstitium, and vessels. All renal marker of graft survival and that an effective antihyper-biopsy samples were independently interpreted by one of the tensive treatment reduces the progression of graft authors without knowledge of the clinical information. damage [14] . Protection of allografts from long-term Glomerular changes observed with light microscopy were functional deterioration is one of the major goals of classified as follows [20, 21] Numerous studies have shown that angiotensin-were considered as chronic lesions. Interstitial fibrosis was converting enzyme (ACE) inhibitors interfere with graded semi-quantitatively as 0, none; 1, mild changes; 2, progressive deterioration of many chronic renal dis-moderate changes; and 3, severe changes. eases, including IgAN [17] . Only one report so far has shown the antiproteinuric efficacy of ACE inhibitors Morphometric analysis in patients with post-transplant glomerulonephritis [18] . The beneficial effect of ACE inhibitors still The method for measuring glomerular diameter (Bowman's remains obscure for post-transplant IgAN, and to date capsule) has been described previously [22] . The geometric there are a few in-depth studies in renal transplantation mean of two diameters measured perpendicular to each other that have analysed the relationship between histo-was calculated. At least five glomeruli showing juxtaglomerular apparatus or vascular pole were selected and analyzed, logical lesions and response to ACE inhibitor treatand means±standard deviations were then calculated for ment [18, 19] . each biopsy.
In this paper, we report the histological characteristics of post-transplant IgAN compared with those of ACE inhibitor treatment and subjects primary IgAN. To address whether ACE inhibitor treatment favourably influences disease progression in Ten patients with post-transplant IgAN, nine men and one post-transplant IgAN, we investigated the effects of an woman aged 14-44 (34±10) years, with stable renal allograft ACE inhibitor on blood pressure and changes in renal function (serum creatinine less than 2 mg/dl ), moderate graft function.
to severe hypertension, and proteinuria (0.3-3.0 g/day) were treated with the ACE inhibitor trandolapril. Written informed consent was obtained from all patients.
Subjects and methods
No patients revealed renal artery graft stenosis after screening by technetium-scan imaging. All patients were given immunosuppressive medications as follows: cyclosporin A Patients (CsA)/prednisolone in six cases, tacrolimus/azathioprine/ prednisolone in two cases, and azathioprine/prednisolone in Post-transplant IgAN was found in 21 patients out of 68 renal biopsy specimens from allograft kidneys from 1997 to two cases. All patients were treated for their hypertension with the calcium-channel blocker nifedipine (20-40 mg/day) 1998 at Osaka University Hospital. These biopsies were performed because of the presence of proteinuria (17 cases) or 2.5-5 mg/day amlodipine besilate. To assess the effectiveness of the ACE inhibitor in the treatment of hypertension, or as non-episode protocol biopsy (four cases). The patients consisted of 16 men and five women, with a mean age of proteinuria, and renal graft function, trandolapril was added at a dose of 1 mg/day to the above regimen and these patients 29±11 years at the time of biopsy. The aetiology of the endstage renal disease was unknown in all patients. The mean were followed for mean duration of 12.8 months (range 12-16 months). Trandolapril is a long-acting ACE inhibitor interval from renal transplantation to the diagnosis of posttransplant IgAN was 2335±1346 days. Interval from the that is metabolized and excreted mainly in the liver. The immunosuppressive and antihypertensive treatment regimen was kept unchanged throughout the study.
Clinical data
Blood pressure was monitored monthly in a seated position after 5 min rest. The effects of trandolapril on proteinuria and renal function were evaluated every 3 months by urinary protein excretion (g/day), and serum creatinine (s-Cr) level (mg/dl ) respectively.
Statistics
Values are expressed as mean±standard deviation. A comparison of the clinical data between before and after the Fig. 1 transplant IgAN, whereas chronic lesions were observed to a similar extent in both primary and posttransplant IgAN. Figure 2 depicts the relationship between the rate of We studied the prevalence of adhesion, crescents, seg-glomerular obsolescence and the severity of glomerular mental sclerosis, global obsolescence, and interstitial lesions in primary IgAN and in post-transplant IgAN. fibrosis in both post-transplant and primary IgAN In primary IgAN the rate of glomerular obsolescence (Figure 1 ). The prevalence of glomeruli with adhesions correlated with the severity of the glomerular lesion. and cellular crescents was significantly greater in In contrast, in post-transplant IgAN a high percentage primas than in post-transplant IgAN (P<0.05), while of glomerular obsolescence was observed irrespective the prevalence of glomeruli with segmental sclerosis of the severity of the glomerular lesion. was similar in both groups. The rate of global obsolescence and the average score of interstitial fibrosis in The relationship between interstitial fibrosis and post-transplant IgAN were significantly greater than glomerular lesion in primary IgAN (P<0.05). The lesions analysed here have been used to compare the activity or chronicity Figure 3 shows the relationship between the severity of interstitial fibrosis and the severity of glomerular of lesions in primary IgAN [20, 23] . In the previous works, mesangial proliferation and cellular crescents lesions in primary IgAN and in post-transplant IgAN.
Results

Comparison of adhesion, crescents, segmental sclerosis, The relationship between the degree of glomerular lesion global obsolescence, and interstitial fibrosis between and the prevalence of glomerular obsolescence post-transplant and primary IgAN
In primary IgAN, severe interstitial fibrosis was found were considered as active lesions. Segmental sclerosis, global obsolescence, and interstitial fibrosis were con-in patients with severe glomerular lesions. In contrast, in post-transplant IgAN no correlation was noted sidered as chronic changes. post-transplant IgAN ( Table 2 ). There was a significant correlation between the prevalence of segmental sclerosis and proteinuria in post-transplant IgAN (P<0.05), suggesting that segmental sclerosis is related to the higher urinary protein excretion in posttransplant IgAN.
Effects of trandolapril on hypertension and proteinuria
In light of the histological characteristics of posttransplant IgAN discussed above, we believe that treatment with ACE inhibitors may be efficacious in decreasing urinary protein excretion and further preventing progression of graft function loss. Ten patients of post-transplant IgAN with mild to moderate pro- 5 and 6 show the changes in blood pressure and urinary protein excretion before and after ACE-inhibitor treatment in individual patients. The blood pressure was between the severity of interstitial fibrosis and that of 150±19/100±11 mmHg (mean arterial pressure the glomerular lesion, because patients with none, or 116.8±13.9) before ACE-inhibitor treatment and mild glomerular lesion of post-transplant IgAN had was significantly decreased to 124±11/82±11 mmHg moderate or severe interstitial fibrosis.
(mean arterial pressure 96.0±11.1) after the treatment.
No acute renal graft function deterioration was The relationship between glomerular diameter and the observed after the initiation of the treatment with prevalence of glomerular obsolescence trandolapril. Figure 4 depicts the relationship between the glomerular diameter of the remnant glomeruli with the rate We compared the prevalence of segmental sclerosis =0.1036 between the patient subgroups with 1.0 g/day or more Á1 g/day 11 7 urinary protein and those with less than 1.0 g/day in
Histopathology of post-transplant IgAN and the effect of ACE inhibition 693 the glomerular changes; (iii) in post-transplant IgAN, glomerular hypertrophy was observed at any grade of glomerular obsolescence. These histopathological characteristics may result from the pathophysiological conditions of the allograft kidneys. Consideration of the underlying factors will provide a useful insight into the therapeutic approach towards protecting the allograft kidneys from deteriorating graft function. We speculate that one of the underlying mechanisms of low prevalence of acute lesions in post-transplant IgAN is the effects of immunosuppressive medications such as corticosteroids, azathioprine, and CsA. In primary IgAN, prednisolone alone or prednisolone and azathioprine therapy were shown to improve histologically active lesions [24] [25] [26] . Schwarz et al. [27] reported that CsA did not prevent the recurrence of post-transplant glomerulonephritis including IgAN, but possibly suppressed the disease progression in patients after kidney transplantation. CsA and tacrolimus interfere with the early stage of lymphocyte proliferation by blocking interleukin-2 (IL-2) synthesis. It has been reported that a spontaneous hyperproduction of IL-2 occurred in patients with primary IgAN and that during the acute phase of the disease, such as the macrohaematuria episode, further elevation of IL-2 was observed [28] . In addition, there has been a case report of a patient who developed crescentic IgAN following treatment with recombinant IL-2 [29] . These reports suggest the involvement of IL-2 in acute glomerular lesions such as crescents, and therefore support the potential effect of CsA on the acute glomerular lesions.
In primary IgAN it has been shown that the degree Fig. 6 . The changes of urinary protein excretion before and after of glomerular lesions is closely correlated with that of ACE inhibitor treatment in individual patients. ACEI, ACE tubulointerstitial lesions [25, 30] ; this was also coninhibitor.
firmed in the present study. In addition we found a similar relationship between the degree of glomerular Before treatment, nine out of 10 patients had moder-lesions and the prevalence of glomerular obsolescence ate urinary protein excretion (>1.0 g/day). The mean in primary IgAN. In contrast, in post-transplant IgAN, value of urinary protein excretion in the patients before no correlation was noted between the degree of glomertreatment was 2.7±1.5 g/day (range 0.3-4.8), and was ular lesions and the prevalence of glomerular obsolessignificantly decreased to 0.89±0.65 g/day (range cence, or the severity of interstitial fibrosis. The 0.27-1.9) at the end of this study (P<0.001). There potential explanations for this lack of correlation was no apparent correlation between the percentage between glomerular obsolescence or interstitial fibrosis decrease of blood and the percentage decrease of with the glomerular lesions are listed below. proteinuria (data not shown). The ACE-inhibitor treat-Glomerular obsolescence may result from ischaemic ment effectively improved hypertension as well as injury/collapse of glomeruli due to arteriolosclerosis. proteinuria.
Interstitial fibrosis may be due to the toxic effect of CsA, or result from ureteral obstruction, or may represent the scarring process of acute rejection [31] .
Discussion
No renal biopsy specimen of the post-transplant IgAN revealed chronic rejection defined as obliterative intimal thickening with reduction of vascular lumina. In the present study we have studied the histological characteristics of post-transplant IgAN and primary Increases in glomerular size were more prominent in post-transplant IgAN than in primary IgAN, especially IgAN. As far as we are aware, this is the first systematic analysis of histopathology of post-transplant IgAN. in the absence of glomerular obsolescence. In primary IgAN, glomerular hypertrophy occurred in accordance The main findings are as follows: (i) acute lesions such as mesangial proliferation, crescent formation were with the progression of glomerular obsolescence, supporting the idea that glomerular hypertrophy results rarely found in post-transplant IgAN; (ii) chronic lesions such as glomerular obsolescence and interstitial from a reduction in the number of functioning nephrons by any aetiology [32] . On the contrary, in fibrosis were observed irrespective of the severity of
